UPDATE: UBS Upgrades Luminex (LMNX) to Buy; Summer Sell-off Overdone
Tweet
Share
E-mailGet Alerts LMNX Hot Sheet
Price: $36.99 --0%
Rating Summary:
1 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
1 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
(Updated - August 23, 2012 11:13 AM EDT)
UBS upgraded Luminex (NASDAQ: LMNX) from Neutral to Buy. PT lowered from $25 to $22.
Analyst, Daniel Arias, said, "We are upgrading LMNX as we view the stock as over-sold (-13% YTD) following dilutive M&A, a negative media report on BioWatch, & competitive fears. At ~2.8x 2013 estimates (EV/sales), LMNX now trades at a discount to peers & historical levels; going forward, we see multiple expansion via execution on near-term catalysts/events – i.e. ramping GPP uptake, new assay launches, & EraGen expansion. Additionally, low NIH exposure, a high % of recurring revenues, and a focus on clinical markets make for a favorable profile amidst macro challenges."
FY12/13 EPS estimate maintaine at $0.33/$0.51, respectively.
For an analyst ratings summary and ratings history on Luminex click here. For more ratings news on Luminex click here.
Shares of Luminex closed at $18.41 yesterday.
UBS upgraded Luminex (NASDAQ: LMNX) from Neutral to Buy. PT lowered from $25 to $22.
Analyst, Daniel Arias, said, "We are upgrading LMNX as we view the stock as over-sold (-13% YTD) following dilutive M&A, a negative media report on BioWatch, & competitive fears. At ~2.8x 2013 estimates (EV/sales), LMNX now trades at a discount to peers & historical levels; going forward, we see multiple expansion via execution on near-term catalysts/events – i.e. ramping GPP uptake, new assay launches, & EraGen expansion. Additionally, low NIH exposure, a high % of recurring revenues, and a focus on clinical markets make for a favorable profile amidst macro challenges."
FY12/13 EPS estimate maintaine at $0.33/$0.51, respectively.
For an analyst ratings summary and ratings history on Luminex click here. For more ratings news on Luminex click here.
Shares of Luminex closed at $18.41 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alpine Income Property Trust (PINE) PT Lowered to $18 at Jones Trading
- Uber Inc. (UBER) PT Raised to $96 at Tigress Financial Partners
- HSBC Downgrades Feng Tay Enterprises (9910:TT) to Hold
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
